GLP1agoniistit

GLP-1 agonists are a class of medications that mimic the actions of the hormone glucagon-like peptide-1 (GLP-1). GLP-1 is naturally produced by the body and plays a crucial role in regulating blood sugar levels, appetite, and insulin secretion. GLP-1 agonists are primarily used to manage type 2 diabetes and, in some cases, obesity. They work by stimulating the pancreas to produce more insulin, reducing the amount of glucose released by the liver, and slowing down gastric emptying, which helps control blood sugar levels. Commonly prescribed GLP-1 agonists include exenatide (Byetta, Bydureon), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and semaglutide (Ozempic, Rybelsus). These medications are typically administered via injection or as an oral tablet. Side effects may include nausea, vomiting, diarrhea, and injection site reactions. Long-term use of GLP-1 agonists can lead to weight loss, which is a beneficial side effect for some patients. It is important to note that GLP-1 agonists should be used under medical supervision, as they can cause serious side effects such as pancreatitis and thyroid cancer.